P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical a...

por Specht, HM, Pelzel, J, Hautmann, H, Huber, RM, Schossow, B, Molls, M, Multhoff, G
Publicado 2014

Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats

por Shevtsov, M. A., Parr, M. A., Ryzhov, V. A., Zemtsova, E. G., Arbenin, A. Yu, Ponomareva, A. N., Smirnov, V. M., Multhoff, G.
Publicado 2016

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients

por Summerer, I, Unger, K, Braselmann, H, Schuettrumpf, L, Maihoefer, C, Baumeister, P, Kirchner, T, Niyazi, M, Sage, E, Specht, H M, Multhoff, G, Moertl, S, Belka, C, Zitzelsberger, H
Publicado 2015